CORD-19:fccc2cff358d6c08f512003b88bab9934e4ffa7a / 13767-14085 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T95","span":{"begin":0,"end":318},"obj":"Sentence"},{"id":"TextSentencer_T95","span":{"begin":0,"end":318},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"To answer this question, we compared the inhibitory activity of 3HP-β-LG with that of 3-hydroxyphthalic anhydride-modified human serum albumin (3HP-HSA) and 3-hydroxyphthalic anhydride-modified chicken ovalbumin (3HP-OVA) against entry of HPV16 PsV into HeLa cells, using the unmodified β-LG, HSA, and OVA as controls."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T14","span":{"begin":129,"end":134},"obj":"Body_part"}],"attributes":[{"id":"A14","pred":"uberon_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"To answer this question, we compared the inhibitory activity of 3HP-β-LG with that of 3-hydroxyphthalic anhydride-modified human serum albumin (3HP-HSA) and 3-hydroxyphthalic anhydride-modified chicken ovalbumin (3HP-OVA) against entry of HPV16 PsV into HeLa cells, using the unmodified β-LG, HSA, and OVA as controls."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T30","span":{"begin":148,"end":151},"obj":"Disease"},{"id":"T31","span":{"begin":293,"end":296},"obj":"Disease"},{"id":"T63136","span":{"begin":148,"end":151},"obj":"Disease"},{"id":"T40274","span":{"begin":293,"end":296},"obj":"Disease"}],"attributes":[{"id":"A30","pred":"mondo_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/MONDO_0011848"},{"id":"A31","pred":"mondo_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/MONDO_0011848"},{"id":"A17089","pred":"mondo_id","subj":"T63136","obj":"http://purl.obolibrary.org/obo/MONDO_0011848"},{"id":"A79838","pred":"mondo_id","subj":"T40274","obj":"http://purl.obolibrary.org/obo/MONDO_0011848"}],"text":"To answer this question, we compared the inhibitory activity of 3HP-β-LG with that of 3-hydroxyphthalic anhydride-modified human serum albumin (3HP-HSA) and 3-hydroxyphthalic anhydride-modified chicken ovalbumin (3HP-OVA) against entry of HPV16 PsV into HeLa cells, using the unmodified β-LG, HSA, and OVA as controls."}